Thymosin Alpha-1 Dosage in 2026: What Clinicians Actually Prescribe

Thymosin Alpha-1 at a glance:

• Drug class: Immunomodulatory peptide
• Route: subcutaneous injection
• Typical frequency: twice weekly in approved hepatitis B regimens
• Half-life: approximately 2 hours
• Cash price (US): varies by country; not commercially available in US

Most people who quit Thymosin Alpha-1 do it during titration, and most of those quits trace to dosing decisions. Get the schedule right and the rest is much easier.

Standard Dosing Schedule for Thymosin Alpha-1

Approved hepatitis B dosing is typically 1.6 mg subcutaneously twice weekly for 6 months.

The typical schedule for Thymosin Alpha-1 is twice weekly in approved hepatitis B regimens via subcutaneous injection. Half-life of approximately 2 hours explains why this schedule works — the drug stays active long enough to support that interval.

Titration: Why Starting Low Matters

For this class of compound, gradual titration is the standard approach. The starting doses listed above are not therapeutic — they exist to let the body adapt and to reduce gastrointestinal symptoms .

A typical titration plan for Thymosin Alpha-1 holds each dose step for at least four weeks before moving up. Faster titration is associated with more dropouts due to side effects.

Missed Doses

If a dose of Thymosin Alpha-1 is missed: for weekly schedules, the rule of thumb is to take it as soon as remembered if within a defined window, otherwise skip it and resume the regular schedule. The exact window depends on the half-life (approximately 2 hours) and the specific product label. Never double up to make up for a missed dose.

Dose Adjustments

Dose adjustments may be needed for the following:

• Significant weight loss or weight gain
• Side-effect intolerance at the current step
• Changes in renal or hepatic function
• Drug interactions (particularly relevant for any concurrent medications)

We cover the side-effect side of dose decisions in Thymosin Alpha-1 side effects and the cost angle of dose escalation in Thymosin Alpha-1 cost.

What the Trials Used

Published trial data for Thymosin Alpha-1 comes primarily from: Multiple hepatitis B trials forming the basis for ex-US approval.

That data drives the labeled dosing range, which is what physicians prescribe by.

Special Populations

The dosing guidance above applies to general adult use. Special populations — pregnancy, pediatric, severe renal impairment, hepatic dysfunction, elderly with frailty — require individualized assessment that this page can't substitute for.

For Thymosin Alpha-1: the standard contraindications for this drug class apply.

Bottom Line

Dosing Thymosin Alpha-1 is a long game. Get the titration right, hold steady, and adjust deliberately based on how your body responds.

Frequently Asked Questions

Related Reading

• Thymosin Alpha-1 Explained: How It Works and Who It's For
• Thymosin Alpha-1 Side Effects: The Complete List and How to Handle Them
• Does Thymosin Alpha-1 Really Work? An Evidence-Based Results Review
• The Real Thymosin Alpha-1 Price Tag in 2026 — With and Without Insurance
• What Is BPC-157? Everything You Should Know Before Starting
• Is BPC-157 Safe? An Honest Look at the Side-Effect Profile

Sources

• Goldstein AL et al. Thymosin β4: A Multi-Functional Regenerative Peptide. Annals NY Acad Sci 2012;1269:1.
• Sosne G et al. Thymosin Beta 4: A Potential Novel Therapy for Neurotrophic Keratopathy. Expert Opinion 2015;15:663.
• Sikiric P et al. Stable Gastric Pentadecapeptide BPC 157 — Major Wound-Healing Properties. Pharmaceuticals 2020;13:155.

This page is informational only and is not medical advice. We do not provide guidance for self-administration of compounds that are not FDA-approved.